Advertisement
Sentinel lymph node biopsy is underused for high-risk squamous cell carcinoma of the skin

Sentinel Lymph Node Biopsy Underused in High-Risk SCC

0
<0.1 percent of patients with high-risk SCC tumors underwent SLNB; 14 percent underwent dissections
In patients with progressive glioblastoma

Drug Combo Doesn’t Lengthen Glioblastoma Survival

0
Lomustine+bevacizumab may increase progression-free, but not overall, survival versus lomustine alone
Health care experts are supportive of OurNotes

Health Care Experts in Favor of Patient Contribution to Notes

0
With some cautions, experts are supportive of the OurNotes medical notes intervention
Insurance coverage differences account for about half of the disparity in survival rates between black and white patients aged 18 to 64 years with colorectal cancer

Insurance Underlies Black-White Survival Disparity in CRC

0
54 percent of excess risk of death in black colorectal cancer patients accounted for by insurance matching
African-American women with type 2 diabetes appear to be at increased risk of developing estrogen receptor-negative (ER-) breast cancer

ER- Breast CA Risk Up for African-Americans With T2DM

0
ER- type accounts for increased breast cancer risk in African-American women; highest risk in nonobese
Fewer than half of younger adults with colorectal cancer undergo mismatch repair deficiency of DNA testing

Use of MMR Deficiency Testing in Younger CRC Patients Is Low

0
Just 43.1 percent underwent mismatch repair deficiency of DNA testing
About one in five U.S. adults currently uses any tobacco product

About 20 Percent of U.S. Adults Currently Use Tobacco Products

0
Overall, 15.1 percent use cigarettes, with higher use among males, older adults, those with lower incomes
The adoption of state oral chemotherapy parity laws has improved financial protection for many patients

Oral Chemotherapy Parity Laws Offer Some Financial Protection

0
Decrease in estimated out-of-pocket spending at the 25th, 50th, 75th percentiles; increase at 90th, 95th
Adipocytes metabolize and inactivate the anthracycline daunorubicin

Adipocytes Metabolize, Inactivate Daunorubicin

0
Adipocytes metabolize daunorubicin to daunorubicinol, reducing its anti-leukemia effect
When adjuvant endocrine therapy for estrogen receptor-positive breast cancer is stopped after five years

Breast Cancer Recurrences Steady After Therapy Cessation

0
Women with ER-positive BC who stop therapy after 5 years have steady recurrence rate up to 20 years